Towa Pharmaceutical Co., Ltd. (TWAPF)
25.98
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
Towa Pharmaceutical Profit Margin (Quarterly) : 7.75% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.75% |
| March 31, 2026 | -16.99% |
| December 31, 2025 | 12.05% |
| September 30, 2025 | 8.73% |
| June 30, 2025 | 3.86% |
| March 31, 2025 | 6.62% |
| December 31, 2024 | 11.47% |
| September 30, 2024 | 1.74% |
| June 30, 2024 | 8.78% |
| March 31, 2024 | 7.81% |
| December 31, 2023 | 7.49% |
| September 30, 2023 | 4.17% |
| June 30, 2023 | 8.71% |
| March 31, 2023 | 0.32% |
| December 31, 2022 | -1.42% |
| September 30, 2022 | 2.87% |
| June 30, 2022 | 3.03% |
| March 31, 2022 | 2.28% |
| December 31, 2021 | 13.28% |
| September 30, 2021 | 10.00% |
| June 30, 2021 | 12.37% |
| March 31, 2021 | 11.38% |
| December 31, 2020 | 7.87% |
| September 30, 2020 | 8.29% |
| June 30, 2020 | 8.80% |
| Date | Value |
|---|---|
| March 31, 2020 | 13.60% |
| December 31, 2019 | 13.43% |
| September 30, 2019 | 12.26% |
| June 30, 2019 | 13.25% |
| March 31, 2019 | 11.26% |
| December 31, 2018 | 14.67% |
| September 30, 2018 | 11.04% |
| June 30, 2018 | 13.99% |
| March 31, 2018 | -3.81% |
| December 31, 2017 | 11.94% |
| September 30, 2017 | 10.36% |
| June 30, 2017 | 8.91% |
| March 31, 2017 | 3.63% |
| December 31, 2016 | 20.36% |
| September 30, 2016 | 5.82% |
| June 30, 2016 | -5.45% |
| March 31, 2016 | 6.59% |
| December 31, 2015 | 10.39% |
| September 30, 2015 | 8.99% |
| June 30, 2015 | 11.53% |
| March 31, 2015 | 12.02% |
| December 31, 2014 | 24.70% |
| September 30, 2014 | 16.41% |
| June 30, 2014 | 7.78% |
| March 31, 2014 | 5.29% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 9.28% |
| Daiichi Sankyo Co., Ltd. | 11.94% |
| Eisai Co., Ltd. | 8.17% |
| Chugai Pharmaceutical Co., Ltd. | 34.06% |
| Santen Pharmaceutical Co., Ltd. | 10.44% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.73% |
| Return on Assets | 1.78% |
| Return on Invested Capital | 2.07% |
| Gross Profit Margin (Quarterly) | 36.56% |
| Operating Margin (Quarterly) | 9.13% |
| Return on Net Operating Assets | 2.13% |